Neuroone Medical Technologies Corp Total Assets
Neuroone Medical Technologies Corp total assets. Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) holds total assets worth $7.86 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see NMTC stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Neuroone Medical Technologies Corp (2010–2025)
Total assets of Neuroone Medical Technologies Corp from 2010 to 2025. This chart illustrates how Neuroone Medical Technologies Corp's total assets have evolved over time, based on quarterly financial data. See NMTC stock price for real-time trading data and today's change.
Neuroone Medical Technologies Corp - Asset Composition Analysis
Neuroone Medical Technologies Corp Total Assets Breakdown (September 2025)
Neuroone Medical Technologies Corp total assets breakdown as of September 2025. Neuroone Medical Technologies Corp's total assets of $7.86 Million consist of 94.8% current assets and 5.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 60.9% |
| Accounts Receivable | $1.26 Million | 11.7% |
| Inventory | $2.23 Million | 20.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $44.95K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Neuroone Medical Technologies Corp to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neuroone Medical Technologies Corp's current assets represent 94.8% of total assets in 2025, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 60.9% of total assets in 2025, down from 100.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 20.7% of total assets.
Neuroone Medical Technologies Corp Competitors by Total Assets
Key competitors of Neuroone Medical Technologies Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Neuroone Medical Technologies Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.37 | 2.13 | 12.41 |
| Quick Ratio | 3.26 | 1.09 | 12.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.69 Million | $1.99 Million | $8.52 Million |
Neuroone Medical Technologies Corp - Advanced Valuation Insights
This section examines the relationship between Neuroone Medical Technologies Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.76 |
| Latest Market Cap to Assets Ratio | 0.78 |
| Asset Growth Rate (YoY) | 100.9% |
| Total Assets | $10.79 Million |
| Market Capitalization | $8.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Neuroone Medical Technologies Corp's assets below their book value (0.78x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Neuroone Medical Technologies Corp's assets grew by 100.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual total assets of Neuroone Medical Technologies Corp from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $10.79 Million | +100.85% |
| 2024-09-30 | $5.37 Million | -33.68% |
| 2023-09-30 | $8.10 Million | -36.85% |
| 2022-09-30 | $12.82 Million | +61.52% |
| 2021-09-30 | $7.94 Million | +66.78% |
| 2020-09-30 | $4.76 Million | +793.66% |
| 2019-09-30 | $532.62K | +143.52% |
| 2018-09-30 | $218.72K | -71.10% |
| 2017-09-30 | $756.93K | +41082.26% |
| 2016-09-30 | $1.84K | +796.59% |
| 2015-09-30 | $205.00 | -66.28% |
| 2014-09-30 | $608.00 | -45.62% |
| 2013-09-30 | $1.12K | 0.00% |
| 2012-09-30 | $1.12K | -91.93% |
| 2011-09-30 | $13.85K | +51.73% |
| 2010-09-30 | $9.13K | -- |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more